Appendix B: Panel Roster and Financial Disclosures
Herpes (HHV-8/CMV)
| Member | Institution | Financial Disclosure | |
|---|---|---|---|
| Company | Relationship | ||
| Gary Holland | David Geffen School of Medicine at the University of California, Los Angeles | None | N/A |
| Christine Johnston | The University of Washington School of Medicine | Gilead Sciences AbbVie | Consultant |
| Warren Phipps* | University of Washington School of Medicine | None | N/A |
| Ramya Ramaswami | National Institutes of Health | Celgene/Bristol-Myers Squibb | Cooperative Research and Development Agreement |
| EMD Serono | |||
| Merck | |||
| CTI Biopharma | |||
| Shannon Ross | The University of Alabama at Birmingham Heersink School of Medicine | None | N/A |
| * Section Group Lead Note: Members are required to update disclosures annually and to notify guideline staff of any relevant changes in status during the interim. | |||
Download Guidelines
- Section Only PDF (69.1 KB)
- Full Guideline PDF (6.02 MB)
- Tables Only PDF (1.18 MB)